Compare KeyCorp (KEY) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KeyCorp vs Roivant Sciences Ltd. Common Shares — how do they compare? KeyCorp trades at $19.97 (market cap $21.45B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is the larger of the two by market cap, and KeyCorp pays a 4.08% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold KeyCorp for 66 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| KEY | ROIV | |
|---|---|---|
Market Cap | $21.45B | $24.72B |
Volume | 19,450,846 | 6,279,442 |
Sector | Financials | Health |
52-Week High | $23.99 | $41.81 |
52-Week Low | $16.78 | $16.04 |
Typical Hold Time | 66 Days | 1 Days |
Enterprise Value | $34.63B | $20.99B |
Dividend Yield | 4.08% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KeyCorp (KEY) trades at $19.97, up 0.71% with strong recent earnings beats and a 60.79% analyst buy rating. The stock shows bearish technical signals but maintains solid fundamentals with 26.72% net margin and 11.01% ROE. Recent corporate actions include a $0.21 dividend and executive appointments, while cash flow trends show operational stability despite recent net outflows.
KEY presents a compelling value opportunity with 25% upside to consensus target, supported by earnings momentum and dividend stability. Risks include technical bearish pressure, interest rate sensitivity, and competitive dividend landscape. The bank's improved 2026 revenue guidance and institutional accumulation suggest underlying strength despite near-term headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About KeyCorp
With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
Read more on KEY →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
